Anticancer Mechanism of Astragalus Polysaccharide and Its Application in Cancer Immunotherapy

Ziqing He,Xiyu Liu,Simin Qin,Qun Yang,Jintong Na,Zhigang Xue,Liping Zhong
DOI: https://doi.org/10.3390/ph17050636
IF: 4.6
2024-05-16
Pharmaceuticals
Abstract:Astragalus polysaccharide (APS) derived from A. membranaceus plays a crucial role in traditional Chinese medicine. These polysaccharides have shown antitumor effects and are considered safe. Thus, they have become increasingly important in cancer immunotherapy. APS can limit the spread of cancer by influencing immune cells, promoting cell death, triggering cancer cell autophagy, and impacting the tumor microenvironment. When used in combination with other therapies, APS can enhance treatment outcomes and reduce toxicity and side effects. APS combined with immune checkpoint inhibitors, relay cellular immunotherapy, and cancer vaccines have broadened the application of cancer immunotherapy and enhanced treatment effectiveness. By summarizing the research on APS in cancer immunotherapy over the past two decades, this review elaborates on the anticancer mechanism of APS and its use in cancer immunotherapy and clinical trials. Considering the multiple roles of APS, this review emphasizes the importance of using APS as an adjunct to cancer immunotherapy and compares other polysaccharides with APS. This discussion provides insights into the specific mechanism of action of APS, reveals the molecular targets of APS for developing effective clinical strategies, and highlights the wide application of APS in clinical cancer therapy in the future.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?
The paper primarily explores the antitumor mechanisms and applications of Astragalus polysaccharide (APS) in cancer immunotherapy. Specifically, the paper addresses the following key issues: 1. **Mechanism of Action of APS**: APS can exert its anticancer effects through various pathways, including activating immune cells, promoting apoptosis, triggering autophagy in cancer cells, and influencing the tumor microenvironment. 2. **Interaction between APS and Immune Cells**: APS can enhance the functions of immune cells such as dendritic cells (DCs), T cells, and natural killer cells (NK cells). It promotes the maturation and activation of these cells, regulates their quantity and activity, thereby improving the body's immune response to tumors. 3. **Application of APS in Combination Therapy**: When APS is used in combination with other treatment methods such as immune checkpoint inhibitors, adoptive cell immunotherapy, and cancer vaccines, it can enhance therapeutic effects, reduce toxic side effects, and broaden the application scope of cancer immunotherapy. 4. **Impact of APS on Cancer Cells**: APS can interfere with the cell cycle of cancer cells, induce apoptosis, and inhibit signaling pathways such as PI3K/Akt, ERK/MAPK, and NF-κB pathways, thereby inhibiting the proliferation and spread of cancer cells. In summary, this review paper aims to comprehensively elucidate the potential value and application prospects of APS in the field of cancer immunotherapy, emphasizing the importance of APS as an adjuvant therapy, and exploring its specific molecular mechanisms to provide a theoretical basis for developing more effective clinical treatment strategies.